InvestorsHub Logo
Followers 70
Posts 11381
Boards Moderated 0
Alias Born 01/05/2018

Re: centillion post# 385268

Friday, 11/26/2021 12:50:45 PM

Friday, November 26, 2021 12:50:45 PM

Post# of 403047
Nov 26 (Reuters) - Merck & Co (MRK.N) said on Friday updated data from its study of its experimental COVID-19 pill showed the drug was significantly less effective in cutting hospitalizations and deaths than previously reported.

The drugmaker said its pill showed a 30% reduction in hospitalizations and deaths, based on data from 1,433 patients. In October, its data showed a roughly 50% efficacy, based on data from 775 patients. The drug, molnupiravir, was developed with partner Ridgeback Biotherapeutics.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News